PMID- 9492038 OWN - NLM STAT- MEDLINE DCOM- 19980312 LR - 20081121 IS - 0013-7227 (Print) IS - 0013-7227 (Linking) VI - 139 IP - 3 DP - 1998 Mar TI - A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity. PG - 1054-66 AB - The insulin-like growth factor I gene is transcribed from two promoter regions, resulting in alternative first exons in insulin-like growth factor I messenger RNAs. A previous study showed that the sequence from -73 to +44 (where +1 is the first nucleotide in the exon 2 transcription initiation cluster) contained an active exon 2 promoter, and that sequences between -73 and -36 were required for promoter activity. In the current study, the roles of two putative cis-acting elements within the -73 to +44 region in basal exon 2 promoter activity were evaluated using mutagenesis and nuclear protein-DNA binding assays. Mutation of the CCCCACCC sequence at position -53 to GAAATCCC resulted in a complete loss of promoter activity in transient transfection assays in GH3, OVCAR-3, C6, and Chinese hamster ovary (CHO) cells. A -73/+24 exon 2 promoter-luciferase construct had partial promoter activity. Mutation of a putative initiator motif surrounding the major exon 2 start site did not alter the activity of this construct. In electrophoretic mobility shift assays, a 32P-labeled oligomer extending from -73 to +44 in the exon 2 promoter was specifically bound by GH3 cell nuclear extracts. A 32P-labeled oligomer which extended from -63 to -37 in the exon 2 promoter was specifically bound by GH3 and OVCAR-3 cell nuclear extracts. These unlabeled oligomers inhibited the binding of a labeled -236/+44 exon 2 promoter fragment to OVCAR-3 nuclear extracts. Mutation of the CCCCACCC sequence prevented the unlabeled -73/+44 oligomer from inhibiting the binding of the -236/+44 fragment. An unlabeled oligomer containing a consensus activating protein-2 (AP-2)-binding site inhibited labeled -236/+44, -73/+44, and -63/-37 exon 2 promoter binding with a much lower affinity than did the respective unlabeled oligomers. Purified AP-2 protein did not bind to the exon 2 promoter fragment, nor did anti-AP-2 antibody alter the binding. Cotransfection of AP-2 expression vector did not significantly increase exon 2 promoter activity. On the other hand, an oligomer containing a consensus Sp1-binding site inhibited labeled -63/-37 exon 2 promoter binding by GH3 cell nuclear extracts with an affinity similar to that of the unlabeled -63/-37 oligomer. A mutation in the Sp1-binding site in this same oligomer resulted in a complete loss of binding affinity. Purified Sp1 bound to the -63/-37 exon 2 promoter oligomer. Addition of polyclonal antibody to Sp1 resulted in a partial supershift of the complex formed between GH3 cell and OVCAR-3 cell nuclear extracts and the labeled -63/-37 oligomer. However, in Drosophila Schneider cells, which are an experimental model for studying the ability of Sp1 to activate transcription, the -73/+44 exon 2 promoter construct was not stimulated by cotransfection with an Sp1 expression plasmid. UV cross-linking studies indicated that proteins of approximate molecular mass 125, 76, 47, and 38 kDa are bound to the proximal (-236/+44) exon 2 promoter region. It is concluded that the CCCCACCC sequence at -53 is required for exon 2 promoter activity. Moreover, specific binding of nuclear proteins to the proximal exon 2 promoter region requires the CCCCACCC sequence. Sequences downstream of the exon 2 initiation site from +24 to +44 are required for full promoter activity. However, the putative initiator surrounding the major transcription start site at +1 does not appear to be important for the strength of the proximal promoter. The CCCCACCC sequence at -53 appears to be a CACCC box, which binds zinc finger transcription factors of the Kruppel family such as Sp1, although protein factors in addition to Sp1 are required to activate exon 2 transcription through the -73/+44 proximal promoter region. FAU - Wang, X AU - Wang X AD - Department of Biochemistry, University of Texas Health Science Center, San Antonio 78284-7760, USA. FAU - Talamantez, J L AU - Talamantez JL FAU - Adamo, M L AU - Adamo ML LA - eng GR - DK-47357/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Endocrinology JT - Endocrinology JID - 0375040 RN - 0 (DNA-Binding Proteins) RN - 0 (Sp1 Transcription Factor) RN - 0 (Transcription Factor AP-2) RN - 0 (Transcription Factors) RN - 67763-96-6 (Insulin-Like Growth Factor I) SB - IM MH - Animals MH - Base Sequence MH - CHO Cells MH - Cricetinae MH - DNA-Binding Proteins/analysis/metabolism MH - *Exons MH - Humans MH - Insulin-Like Growth Factor I/*genetics MH - Molecular Sequence Data MH - *Promoter Regions, Genetic MH - Rats MH - Sp1 Transcription Factor/metabolism MH - Transcription Factor AP-2 MH - Transcription Factors/metabolism MH - Transfection EDAT- 1998/03/10 00:00 MHDA- 1998/03/10 00:01 CRDT- 1998/03/10 00:00 PHST- 1998/03/10 00:00 [pubmed] PHST- 1998/03/10 00:01 [medline] PHST- 1998/03/10 00:00 [entrez] AID - 10.1210/endo.139.3.5805 [doi] PST - ppublish SO - Endocrinology. 1998 Mar;139(3):1054-66. doi: 10.1210/endo.139.3.5805.